| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | growth factor binding | 2.83e-05 | 156 | 23 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 4.55e-05 | 9 | 23 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 4.55e-05 | 9 | 23 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 8.32e-05 | 12 | 23 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.15e-04 | 14 | 23 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.38e-04 | 27 | 23 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.13e-04 | 599 | 23 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | integrin binding | 1.03e-03 | 175 | 23 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.27e-03 | 188 | 23 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 1.35e-03 | 192 | 23 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 1.75e-03 | 54 | 23 | 2 | GO:0005246 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 2.22e-03 | 1233 | 23 | 6 | GO:0140677 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.53e-03 | 65 | 23 | 2 | GO:0004714 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 3.41e-03 | 554 | 23 | 4 | GO:0030546 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.47e-03 | 268 | 23 | 3 | GO:0005539 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 4.28e-03 | 85 | 23 | 2 | GO:0019199 | |
| GeneOntologyMolecularFunction | virus receptor activity | 4.28e-03 | 85 | 23 | 2 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 4.37e-03 | 86 | 23 | 2 | GO:0140272 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 4.98e-03 | 616 | 23 | 4 | GO:0030545 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 5.84e-03 | 323 | 23 | 3 | GO:1901681 | |
| GeneOntologyMolecularFunction | calcium ion binding | 9.85e-03 | 749 | 23 | 4 | GO:0005509 | |
| GeneOntologyMolecularFunction | hormone activity | 1.05e-02 | 135 | 23 | 2 | GO:0005179 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 7.13e-06 | 4 | 23 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 3.32e-05 | 8 | 23 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 4.26e-05 | 9 | 23 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 6.50e-05 | 11 | 23 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 9.21e-05 | 13 | 23 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 9.21e-05 | 13 | 23 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.38e-04 | 91 | 23 | 3 | GO:0033627 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 1.41e-04 | 16 | 23 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.43e-04 | 92 | 23 | 3 | GO:0051966 | |
| GeneOntologyBiologicalProcess | embryo implantation | 1.67e-04 | 97 | 23 | 3 | GO:0007566 | |
| GeneOntologyBiologicalProcess | lung development | 2.06e-04 | 269 | 23 | 4 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 2.18e-04 | 273 | 23 | 4 | GO:0030323 | |
| GeneOntologyBiologicalProcess | trophoblast cell migration | 2.23e-04 | 20 | 23 | 2 | GO:0061450 | |
| GeneOntologyBiologicalProcess | notochord development | 3.23e-04 | 24 | 23 | 2 | GO:0030903 | |
| GeneOntologyBiologicalProcess | respiratory system development | 3.32e-04 | 305 | 23 | 4 | GO:0060541 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 3.73e-04 | 577 | 23 | 5 | GO:0001667 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 4.13e-04 | 132 | 23 | 3 | GO:0035249 | |
| GeneOntologyBiologicalProcess | astrocyte activation | 4.74e-04 | 29 | 23 | 2 | GO:0048143 | |
| GeneOntologyBiologicalProcess | skeletal system development | 4.99e-04 | 615 | 23 | 5 | GO:0001501 | |
| GeneOntologyBiologicalProcess | tube development | 6.15e-04 | 1402 | 23 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | glial cell development | 6.85e-04 | 157 | 23 | 3 | GO:0021782 | |
| GeneOntologyBiologicalProcess | skin development | 7.10e-04 | 373 | 23 | 4 | GO:0043588 | |
| GeneOntologyBiologicalProcess | embryo development | 7.13e-04 | 1437 | 23 | 7 | GO:0009790 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 8.16e-04 | 38 | 23 | 2 | GO:0007435 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 8.47e-04 | 691 | 23 | 5 | GO:0030335 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 9.86e-04 | 178 | 23 | 3 | GO:0022612 | |
| GeneOntologyBiologicalProcess | salivary gland development | 1.04e-03 | 43 | 23 | 2 | GO:0007431 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 1.05e-03 | 725 | 23 | 5 | GO:2000147 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.08e-03 | 730 | 23 | 5 | GO:0007423 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.16e-03 | 426 | 23 | 4 | GO:0043010 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 1.17e-03 | 742 | 23 | 5 | GO:0040017 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.23e-03 | 192 | 23 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | astrocyte development | 1.25e-03 | 47 | 23 | 2 | GO:0014002 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.28e-03 | 195 | 23 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.54e-03 | 1186 | 23 | 6 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 1.72e-03 | 1211 | 23 | 6 | GO:0030334 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.76e-03 | 218 | 23 | 3 | GO:0090101 | |
| GeneOntologyBiologicalProcess | eye development | 1.80e-03 | 480 | 23 | 4 | GO:0001654 | |
| GeneOntologyBiologicalProcess | exocrine system development | 1.83e-03 | 57 | 23 | 2 | GO:0035272 | |
| GeneOntologyBiologicalProcess | visual system development | 1.85e-03 | 483 | 23 | 4 | GO:0150063 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.96e-03 | 59 | 23 | 2 | GO:0007215 | |
| GeneOntologyBiologicalProcess | sensory system development | 1.96e-03 | 491 | 23 | 4 | GO:0048880 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.18e-03 | 1269 | 23 | 6 | GO:0009887 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 2.28e-03 | 1280 | 23 | 6 | GO:2000145 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.97e-05 | 656 | 23 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.07e-05 | 658 | 23 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.72e-05 | 405 | 23 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | microfibril | 8.97e-05 | 13 | 23 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 3.15e-04 | 122 | 23 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.68e-04 | 583 | 23 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.69e-03 | 817 | 23 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.98e-03 | 230 | 23 | 3 | GO:0019898 | |
| GeneOntologyCellularComponent | cell leading edge | 2.00e-03 | 500 | 23 | 4 | GO:0031252 | |
| GeneOntologyCellularComponent | dendrite | 2.09e-03 | 858 | 23 | 5 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 2.11e-03 | 860 | 23 | 5 | GO:0097447 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.47e-03 | 530 | 23 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.35e-03 | 277 | 23 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | receptor complex | 3.43e-03 | 581 | 23 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | postsynapse | 4.38e-03 | 1018 | 23 | 5 | GO:0098794 | |
| GeneOntologyCellularComponent | vesicle lumen | 5.55e-03 | 332 | 23 | 3 | GO:0031983 | |
| GeneOntologyCellularComponent | excitatory synapse | 6.12e-03 | 107 | 23 | 2 | GO:0060076 | |
| GeneOntologyCellularComponent | ruffle membrane | 6.23e-03 | 108 | 23 | 2 | GO:0032587 | |
| GeneOntologyCellularComponent | cell surface | 6.34e-03 | 1111 | 23 | 5 | GO:0009986 | |
| HumanPheno | Abnormal upper to lower segment ratio | 1.27e-05 | 3 | 11 | 2 | HP:0012772 | |
| HumanPheno | Crumpled ear | 6.33e-05 | 6 | 11 | 2 | HP:0009901 | |
| HumanPheno | Lens dislocation | 8.82e-05 | 43 | 11 | 3 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 8.82e-05 | 43 | 11 | 3 | HP:0001083 | |
| MousePheno | abnormal esophageal epithelium morphology | 1.43e-06 | 17 | 19 | 3 | MP:0000468 | |
| MousePheno | abnormal tongue epithelium morphology | 6.10e-06 | 27 | 19 | 3 | MP:0000764 | |
| MousePheno | subarachnoid hemorrhage | 1.05e-05 | 4 | 19 | 2 | MP:0031109 | |
| MousePheno | abnormal epidermis stratum basale morphology | 1.61e-05 | 37 | 19 | 3 | MP:0001231 | |
| MousePheno | abnormal nail morphology | 2.54e-05 | 43 | 19 | 3 | MP:0000579 | |
| MousePheno | abnormal submandibular gland development | 3.66e-05 | 7 | 19 | 2 | MP:0013541 | |
| MousePheno | decreased respiration | 7.10e-05 | 170 | 19 | 4 | MP:0014274 | |
| MousePheno | abnormal ejaculation | 7.83e-05 | 10 | 19 | 2 | MP:0001378 | |
| MousePheno | abnormal esophagus morphology | 9.23e-05 | 66 | 19 | 3 | MP:0000467 | |
| MousePheno | increased mast cell number | 1.15e-04 | 12 | 19 | 2 | MP:0000324 | |
| MousePheno | enlarged cranium | 2.08e-04 | 16 | 19 | 2 | MP:0000439 | |
| MousePheno | abnormal skin condition | 2.17e-04 | 227 | 19 | 4 | MP:0001191 | |
| MousePheno | craniofacial phenotype | 2.37e-04 | 1372 | 19 | 8 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 2.37e-04 | 1372 | 19 | 8 | MP:0000428 | |
| MousePheno | abnormal pulmonary alveolus wall morphology | 2.95e-04 | 19 | 19 | 2 | MP:0010903 | |
| MousePheno | abnormal skin appearance | 3.41e-04 | 473 | 19 | 5 | MP:0009931 | |
| MousePheno | abnormal tongue morphology | 5.15e-04 | 118 | 19 | 3 | MP:0000762 | |
| MousePheno | abnormal maternal decidual layer morphology | 5.15e-04 | 25 | 19 | 2 | MP:0004256 | |
| MousePheno | dilated kidney collecting duct | 5.15e-04 | 25 | 19 | 2 | MP:0004860 | |
| MousePheno | abnormal cranium morphology | 5.36e-04 | 813 | 19 | 6 | MP:0000438 | |
| MousePheno | cardiac valve regurgitation | 5.58e-04 | 26 | 19 | 2 | MP:0009384 | |
| MousePheno | abnormal submandibular gland morphology | 5.58e-04 | 26 | 19 | 2 | MP:0003793 | |
| MousePheno | abnormal jaw morphology | 5.75e-04 | 530 | 19 | 5 | MP:0000454 | |
| MousePheno | abnormal craniofacial bone morphology | 5.87e-04 | 827 | 19 | 6 | MP:0002116 | |
| MousePheno | abnormal lung interstitium morphology | 6.02e-04 | 27 | 19 | 2 | MP:0002276 | |
| MousePheno | abnormal mast cell number | 6.02e-04 | 27 | 19 | 2 | MP:0020203 | |
| MousePheno | abnormal heart valve physiology | 7.44e-04 | 30 | 19 | 2 | MP:0011926 | |
| MousePheno | abnormal viscerocranium morphology | 9.57e-04 | 593 | 19 | 5 | MP:0005274 | |
| MousePheno | abnormal platelet morphology | 1.01e-03 | 600 | 19 | 5 | MP:0004720 | |
| MousePheno | abnormal bronchiole morphology | 1.13e-03 | 37 | 19 | 2 | MP:0002267 | |
| MousePheno | abnormal major salivary gland morphology | 1.13e-03 | 37 | 19 | 2 | MP:0003792 | |
| MousePheno | abnormal skeleton physiology | 1.27e-03 | 632 | 19 | 5 | MP:0001533 | |
| MousePheno | abnormal cornea morphology | 1.31e-03 | 366 | 19 | 4 | MP:0001312 | |
| MousePheno | abnormal heart valve morphology | 1.31e-03 | 163 | 19 | 3 | MP:0000285 | |
| MousePheno | respiratory failure | 1.36e-03 | 165 | 19 | 3 | MP:0001953 | |
| MousePheno | abnormal mast cell morphology | 1.46e-03 | 42 | 19 | 2 | MP:0000359 | |
| Domain | EGF-like_CS | 3.20e-07 | 261 | 21 | 6 | IPR013032 | |
| Domain | EGF_2 | 3.50e-07 | 265 | 21 | 6 | PS01186 | |
| Domain | FBN | 3.61e-06 | 3 | 21 | 2 | IPR011398 | |
| Domain | EGF_1 | 7.76e-06 | 255 | 21 | 5 | PS00022 | |
| Domain | Growth_fac_rcpt_ | 2.51e-05 | 156 | 21 | 4 | IPR009030 | |
| Domain | TB | 2.52e-05 | 7 | 21 | 2 | PF00683 | |
| Domain | - | 3.36e-05 | 8 | 21 | 2 | 3.90.290.10 | |
| Domain | GPCR_3_mtglu_rcpt | 3.36e-05 | 8 | 21 | 2 | IPR000162 | |
| Domain | TB | 4.31e-05 | 9 | 21 | 2 | PS51364 | |
| Domain | TB_dom | 4.31e-05 | 9 | 21 | 2 | IPR017878 | |
| Domain | NCD3G | 9.32e-05 | 13 | 21 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 9.32e-05 | 13 | 21 | 2 | IPR011500 | |
| Domain | GPCR_3_CS | 1.09e-04 | 14 | 21 | 2 | IPR017979 | |
| Domain | EGF_3 | 1.24e-04 | 235 | 21 | 4 | PS50026 | |
| Domain | EGF | 1.24e-04 | 235 | 21 | 4 | SM00181 | |
| Domain | EGF-like_dom | 1.54e-04 | 249 | 21 | 4 | IPR000742 | |
| Domain | GPCR_3 | 2.50e-04 | 21 | 21 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 2.74e-04 | 22 | 21 | 2 | PS50259 | |
| Domain | EPHD | 2.74e-04 | 22 | 21 | 2 | PS51805 | |
| Domain | 7tm_3 | 2.74e-04 | 22 | 21 | 2 | PF00003 | |
| Domain | GPCR_3_C | 2.74e-04 | 22 | 21 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 2.74e-04 | 22 | 21 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 2.74e-04 | 22 | 21 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 2.74e-04 | 22 | 21 | 2 | PS00979 | |
| Domain | EGF_CA | 3.32e-04 | 122 | 21 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.48e-04 | 124 | 21 | 3 | IPR001881 | |
| Domain | cEGF | 3.85e-04 | 26 | 21 | 2 | IPR026823 | |
| Domain | cEGF | 3.85e-04 | 26 | 21 | 2 | PF12662 | |
| Domain | Znf_FYVE_PHD | 5.73e-04 | 147 | 21 | 3 | IPR011011 | |
| Domain | ANF_receptor | 7.83e-04 | 37 | 21 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 7.83e-04 | 37 | 21 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 8.70e-04 | 39 | 21 | 2 | IPR028082 | |
| Domain | PHD | 3.18e-03 | 75 | 21 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 3.52e-03 | 79 | 21 | 2 | IPR019787 | |
| Domain | EGF_CA | 4.16e-03 | 86 | 21 | 2 | PF07645 | |
| Domain | TyrKc | 4.35e-03 | 88 | 21 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 4.35e-03 | 88 | 21 | 2 | IPR020635 | |
| Domain | PHD | 4.45e-03 | 89 | 21 | 2 | SM00249 | |
| Domain | Znf_PHD | 4.64e-03 | 91 | 21 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.05e-03 | 95 | 21 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 5.15e-03 | 96 | 21 | 2 | PS01359 | |
| Domain | PROTEIN_KINASE_TYR | 5.26e-03 | 97 | 21 | 2 | PS00109 | |
| Domain | EGF_Ca-bd_CS | 5.26e-03 | 97 | 21 | 2 | IPR018097 | |
| Domain | Tyr_kinase_AS | 5.26e-03 | 97 | 21 | 2 | IPR008266 | |
| Domain | EGF_CA | 5.47e-03 | 99 | 21 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.58e-03 | 100 | 21 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.25e-03 | 106 | 21 | 2 | IPR000152 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.42e-04 | 15 | 17 | 2 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.42e-04 | 15 | 17 | 2 | MM15845 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.16e-04 | 258 | 17 | 4 | MM14572 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.22e-04 | 114 | 17 | 3 | MM14571 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.84e-04 | 121 | 17 | 3 | M39823 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.84e-04 | 300 | 17 | 4 | M610 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 4.04e-04 | 25 | 17 | 2 | M39713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 4.04e-04 | 25 | 17 | 2 | M47934 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 5.53e-04 | 137 | 17 | 3 | M145 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.84e-04 | 30 | 17 | 2 | M27216 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.89e-04 | 140 | 17 | 3 | M587 | |
| Pathway | WP_PI3KAKT_SIGNALING | 6.10e-04 | 339 | 17 | 4 | M39736 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.65e-04 | 32 | 17 | 2 | MM14854 | |
| Pathway | PID_ARF6_PATHWAY | 7.96e-04 | 35 | 17 | 2 | M86 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.89e-04 | 37 | 17 | 2 | M27134 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 8.89e-04 | 37 | 17 | 2 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 9.88e-04 | 39 | 17 | 2 | M793 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 9.88e-04 | 39 | 17 | 2 | MM14601 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 1.09e-03 | 41 | 17 | 2 | M232 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.26e-03 | 44 | 17 | 2 | M26969 | |
| Pathway | WP_RAS_SIGNALING | 1.30e-03 | 184 | 17 | 3 | M39764 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.37e-03 | 46 | 17 | 2 | M239 | |
| Pathway | PID_TXA2PATHWAY | 2.03e-03 | 56 | 17 | 2 | M99 | |
| Pubmed | 5.54e-08 | 12 | 23 | 3 | 26405179 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 12399449 | ||
| Pubmed | Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer. | 4.18e-07 | 2 | 23 | 2 | 32417448 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 21851253 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 12429739 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 27401248 | ||
| Pubmed | EphA2 is a functional receptor for the growth factor progranulin. | 4.18e-07 | 2 | 23 | 2 | 27903606 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 4.18e-07 | 2 | 23 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 4.18e-07 | 2 | 23 | 2 | 21440062 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 15131124 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 4.18e-07 | 2 | 23 | 2 | 12524050 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 4.18e-07 | 2 | 23 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 4.18e-07 | 2 | 23 | 2 | 8791520 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 21516087 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 8120105 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 4.18e-07 | 2 | 23 | 2 | 8307578 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 4.18e-07 | 2 | 23 | 2 | 10504303 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 4.18e-07 | 2 | 23 | 2 | 7744963 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 4.18e-07 | 2 | 23 | 2 | 18006876 | |
| Pubmed | Cell adhesion and EGFR activation regulate EphA2 expression in cancer. | 4.18e-07 | 2 | 23 | 2 | 19948216 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 4.18e-07 | 2 | 23 | 2 | 24833718 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24265020 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 20529844 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 4.18e-07 | 2 | 23 | 2 | 25524144 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 23133647 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 4.18e-07 | 2 | 23 | 2 | 16407178 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 4.18e-07 | 2 | 23 | 2 | 1852206 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 10359653 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.10e-07 | 1201 | 23 | 8 | 35696571 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 10825173 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 30201140 | ||
| Pubmed | Progranulin expression in breast cancer with different intrinsic subtypes. | 1.25e-06 | 3 | 23 | 2 | 22397762 | |
| Pubmed | An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer. | 1.25e-06 | 3 | 23 | 2 | 26549523 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 20855508 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 21527992 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 12429738 | ||
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 2.51e-06 | 4 | 23 | 2 | 25406291 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 20729550 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 2.51e-06 | 4 | 23 | 2 | 25034023 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 16835936 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 27641064 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 19469909 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 26996299 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 26381405 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 26601954 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 12590922 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 17255108 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 34411563 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 4.18e-06 | 5 | 23 | 2 | 23493297 | |
| Pubmed | 4.85e-06 | 50 | 23 | 3 | 23658023 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 6.21e-06 | 184 | 23 | 4 | 32908313 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 7873879 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 9022052 | ||
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 6.48e-06 | 55 | 23 | 3 | 38945485 | |
| Pubmed | Regulation of limb patterning by extracellular microfibrils. | 8.77e-06 | 7 | 23 | 2 | 11470817 | |
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 9920659 | ||
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 26350464 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 1.17e-05 | 8 | 23 | 2 | 23055981 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 1.17e-05 | 8 | 23 | 2 | 31201465 | |
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 25202019 | ||
| Pubmed | Targeting of bone morphogenetic protein growth factor complexes to fibrillin. | 1.17e-05 | 8 | 23 | 2 | 18339631 | |
| Pubmed | 1.50e-05 | 9 | 23 | 2 | 12122015 | ||
| Pubmed | 1.50e-05 | 9 | 23 | 2 | 38844137 | ||
| Pubmed | 1.65e-05 | 75 | 23 | 3 | 15951569 | ||
| Pubmed | 1.88e-05 | 10 | 23 | 2 | 30738849 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 1.88e-05 | 10 | 23 | 2 | 9069281 | |
| Pubmed | 1.88e-05 | 10 | 23 | 2 | 17156446 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 2.29e-05 | 11 | 23 | 2 | 17023412 | |
| Pubmed | 2.75e-05 | 12 | 23 | 2 | 36779913 | ||
| Pubmed | 2.75e-05 | 12 | 23 | 2 | 11891216 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.04e-05 | 101 | 23 | 3 | 23382219 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 6.36e-05 | 18 | 23 | 2 | 35503090 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 6.36e-05 | 18 | 23 | 2 | 39040056 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.57e-05 | 135 | 23 | 3 | 28675934 | |
| Pubmed | 9.59e-05 | 22 | 23 | 2 | 15657067 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.14e-04 | 24 | 23 | 2 | 35746896 | |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 1.24e-04 | 25 | 23 | 2 | 15254900 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.35e-04 | 26 | 23 | 2 | 34189436 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 1.80e-04 | 30 | 23 | 2 | 32882513 | |
| Pubmed | 1.80e-04 | 30 | 23 | 2 | 20301299 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.92e-04 | 31 | 23 | 2 | 31550482 | |
| Pubmed | 1.92e-04 | 31 | 23 | 2 | 25762570 | ||
| Pubmed | 2.06e-04 | 175 | 23 | 3 | 28071719 | ||
| Pubmed | 2.60e-04 | 36 | 23 | 2 | 35167946 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 2.75e-04 | 37 | 23 | 2 | 34323105 | |
| Pubmed | 2.87e-04 | 196 | 23 | 3 | 19334288 | ||
| Pubmed | 2.90e-04 | 38 | 23 | 2 | 25613138 | ||
| Pubmed | 3.21e-04 | 40 | 23 | 2 | 30898150 | ||
| Pubmed | 3.21e-04 | 40 | 23 | 2 | 30578393 | ||
| Pubmed | 3.77e-04 | 215 | 23 | 3 | 36808153 | ||
| Pubmed | 4.07e-04 | 45 | 23 | 2 | 25979088 | ||
| Pubmed | 4.25e-04 | 46 | 23 | 2 | 20301533 | ||
| Pubmed | 4.25e-04 | 46 | 23 | 2 | 35022314 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 5.44e-04 | 52 | 23 | 2 | 30389913 | |
| Pubmed | 5.44e-04 | 52 | 23 | 2 | 19328558 | ||
| Pubmed | Targeted Disruption of Mouse Dip2B Leads to Abnormal Lung Development and Prenatal Lethality. | 5.65e-04 | 53 | 23 | 2 | 33153107 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 5.71e-04 | 248 | 23 | 3 | 24006456 | |
| Pubmed | 5.86e-04 | 54 | 23 | 2 | 36237976 | ||
| Interaction | GRM4 interactions | 2.13e-07 | 11 | 23 | 3 | int:GRM4 | |
| Interaction | MFAP5 interactions | 2.77e-05 | 52 | 23 | 3 | int:MFAP5 | |
| Interaction | NISCH interactions | 3.01e-05 | 160 | 23 | 4 | int:NISCH | |
| Interaction | ZFP41 interactions | 3.65e-05 | 57 | 23 | 3 | int:ZFP41 | |
| Interaction | HRG interactions | 4.93e-05 | 63 | 23 | 3 | int:HRG | |
| Interaction | FBN2 interactions | 5.42e-05 | 65 | 23 | 3 | int:FBN2 | |
| Interaction | ITGA3 interactions | 6.20e-05 | 68 | 23 | 3 | int:ITGA3 | |
| Interaction | MFAP2 interactions | 8.17e-05 | 12 | 23 | 2 | int:MFAP2 | |
| Interaction | FBXO2 interactions | 8.56e-05 | 411 | 23 | 5 | int:FBXO2 | |
| Interaction | ADAMTSL1 interactions | 9.64e-05 | 13 | 23 | 2 | int:ADAMTSL1 | |
| Interaction | VOPP1 interactions | 9.64e-05 | 13 | 23 | 2 | int:VOPP1 | |
| Interaction | KRTAP15-1 interactions | 1.05e-04 | 81 | 23 | 3 | int:KRTAP15-1 | |
| Cytoband | 8q24.3 | 1.47e-03 | 113 | 23 | 2 | 8q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 3.55e-03 | 177 | 23 | 2 | chr15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 1.03e-02 | 307 | 23 | 2 | chr17q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.36e-02 | 355 | 23 | 2 | chr8q24 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.13e-05 | 8 | 12 | 2 | 281 | |
| GeneFamily | PHD finger proteins | 1.57e-03 | 90 | 12 | 2 | 88 | |
| GeneFamily | Fibronectin type III domain containing | 4.85e-03 | 160 | 12 | 2 | 555 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.71e-02 | 394 | 12 | 2 | 471 | |
| Coexpression | NABA_CORE_MATRISOME | 3.23e-06 | 270 | 23 | 5 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.17e-05 | 191 | 23 | 4 | MM17059 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 4.96e-05 | 795 | 23 | 6 | M39050 | |
| Coexpression | NABA_CORE_MATRISOME | 8.97e-05 | 275 | 23 | 4 | M5884 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 3.71e-06 | 408 | 23 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 2.77e-05 | 165 | 23 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 1.70e-04 | 806 | 23 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_200 | 1.90e-04 | 19 | 23 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.39e-04 | 288 | 23 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 3.01e-04 | 122 | 23 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-08 | 185 | 23 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-08 | 185 | 23 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-08 | 186 | 23 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-06 | 169 | 23 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-06 | 174 | 23 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-06 | 179 | 23 | 4 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-06 | 180 | 23 | 4 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 184 | 23 | 4 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 184 | 23 | 4 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-06 | 186 | 23 | 4 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 189 | 23 | 4 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 189 | 23 | 4 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 189 | 23 | 4 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-06 | 191 | 23 | 4 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-06 | 192 | 23 | 4 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 192 | 23 | 4 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 192 | 23 | 4 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.73e-06 | 193 | 23 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 193 | 23 | 4 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 194 | 23 | 4 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.78e-06 | 194 | 23 | 4 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 194 | 23 | 4 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-06 | 196 | 23 | 4 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-06 | 196 | 23 | 4 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-06 | 196 | 23 | 4 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-06 | 196 | 23 | 4 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-06 | 197 | 23 | 4 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-06 | 197 | 23 | 4 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-06 | 197 | 23 | 4 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-06 | 197 | 23 | 4 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-06 | 197 | 23 | 4 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-06 | 197 | 23 | 4 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-06 | 198 | 23 | 4 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-06 | 198 | 23 | 4 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 198 | 23 | 4 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-06 | 199 | 23 | 4 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | proximal-Epithelial-Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | c6a491d3e2dae6618f25dc3c9aac08f657348168 | |
| ToppCell | proximal-Epithelial-Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | f5d48f521abbd1e07de05f2b3768ad2f9675f1e1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-06 | 200 | 23 | 4 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | proximal-3-Epithelial-Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | 8083047c213488e40b975013e3c5c43f7c0c15b2 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.01e-05 | 157 | 23 | 3 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.15e-05 | 158 | 23 | 3 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.15e-05 | 158 | 23 | 3 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.15e-05 | 158 | 23 | 3 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.28e-05 | 159 | 23 | 3 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.98e-05 | 164 | 23 | 3 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 8.72e-05 | 169 | 23 | 3 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.72e-05 | 169 | 23 | 3 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-05 | 169 | 23 | 3 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.72e-05 | 169 | 23 | 3 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-05 | 170 | 23 | 3 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-05 | 170 | 23 | 3 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.88e-05 | 170 | 23 | 3 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.88e-05 | 170 | 23 | 3 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-05 | 170 | 23 | 3 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.03e-05 | 171 | 23 | 3 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.03e-05 | 171 | 23 | 3 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 172 | 23 | 3 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 172 | 23 | 3 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 172 | 23 | 3 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-05 | 173 | 23 | 3 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-05 | 173 | 23 | 3 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.51e-05 | 174 | 23 | 3 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.51e-05 | 174 | 23 | 3 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.67e-05 | 175 | 23 | 3 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 175 | 23 | 3 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 176 | 23 | 3 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 176 | 23 | 3 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 177 | 23 | 3 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 179 | 23 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 179 | 23 | 3 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.03e-04 | 179 | 23 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 180 | 23 | 3 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 180 | 23 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 180 | 23 | 3 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 180 | 23 | 3 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 180 | 23 | 3 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-04 | 180 | 23 | 3 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.07e-04 | 181 | 23 | 3 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 181 | 23 | 3 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 23 | 3 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-04 | 181 | 23 | 3 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.07e-04 | 181 | 23 | 3 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 23 | 3 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 23 | 3 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 23 | 3 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 23 | 3 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 23 | 3 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.09e-04 | 182 | 23 | 3 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 182 | 23 | 3 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 182 | 23 | 3 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 182 | 23 | 3 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-04 | 182 | 23 | 3 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.09e-04 | 182 | 23 | 3 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 182 | 23 | 3 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 182 | 23 | 3 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 182 | 23 | 3 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-04 | 182 | 23 | 3 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 182 | 23 | 3 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 183 | 23 | 3 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| Computational | Intermediate filaments. | 1.71e-04 | 75 | 16 | 3 | MODULE_154 | |
| Computational | Genes in the cancer module 297. | 2.07e-04 | 80 | 16 | 3 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 2.07e-04 | 80 | 16 | 3 | MODULE_357 | |
| Computational | ECM and collagens. | 2.79e-04 | 225 | 16 | 4 | MODULE_47 | |
| Computational | Genes in the cancer module 321. | 5.59e-04 | 112 | 16 | 3 | MODULE_321 | |
| Computational | Neighborhood of EGFR | 1.00e-03 | 32 | 16 | 2 | GNF2_EGFR | |
| Computational | Neighborhood of MMP1 | 1.00e-03 | 32 | 16 | 2 | GNF2_MMP1 | |
| Computational | Adhesion molecules. | 1.09e-03 | 141 | 16 | 3 | MODULE_122 | |
| Computational | Neighborhood of TIMP2 | 2.07e-03 | 46 | 16 | 2 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.35e-03 | 49 | 16 | 2 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.44e-03 | 50 | 16 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes in the cancer module 287. | 2.44e-03 | 50 | 16 | 2 | MODULE_287 | |
| Computational | Genes in the cancer module 175. | 2.84e-03 | 54 | 16 | 2 | MODULE_175 | |
| Computational | Placenta genes. | 4.09e-03 | 463 | 16 | 4 | MODULE_38 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 5.92e-03 | 835 | 16 | 5 | MODULE_88 | |
| Drug | Su-M | 2.07e-07 | 52 | 23 | 4 | CID000446388 | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 1.30e-06 | 195 | 23 | 5 | 4653_DN | |
| Drug | cis-MCG-I | 2.72e-05 | 8 | 23 | 2 | CID003035584 | |
| Drug | Propolis | 2.97e-05 | 60 | 23 | 3 | ctd:D011429 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 3.50e-05 | 9 | 23 | 2 | CID000107216 | |
| Drug | mM PEP | 3.50e-05 | 9 | 23 | 2 | CID005311462 | |
| Drug | AC1N21PP | 3.50e-05 | 9 | 23 | 2 | CID004014619 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 3.91e-05 | 193 | 23 | 4 | 6400_DN | |
| Drug | homocysteic acid | 3.95e-05 | 66 | 23 | 3 | CID000092117 | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A | 4.07e-05 | 195 | 23 | 4 | 2707_DN | |
| Drug | NS-105 | 4.37e-05 | 10 | 23 | 2 | CID000198695 | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; HL60; HT_HG-U133A | 4.49e-05 | 200 | 23 | 4 | 3020_UP | |
| Drug | cyclobutylene AP5 | 5.34e-05 | 11 | 23 | 2 | CID000126582 | |
| Drug | AC1L1DME | 5.80e-05 | 75 | 23 | 3 | CID000002414 | |
| Drug | tetrathiomolybdate | 6.52e-05 | 78 | 23 | 3 | ctd:C020809 | |
| Drug | AC1NSKBB | 7.56e-05 | 13 | 23 | 2 | CID005311256 | |
| Drug | Mspg | 7.56e-05 | 13 | 23 | 2 | CID003964410 | |
| Drug | MSOPPE | 7.56e-05 | 13 | 23 | 2 | CID005311463 | |
| Drug | 2-methyl-6-styrylpyridine | 8.82e-05 | 14 | 23 | 2 | CID000235382 | |
| Drug | MTPG | 8.82e-05 | 14 | 23 | 2 | CID005311456 | |
| Drug | Rgd Peptide | 8.96e-05 | 239 | 23 | 4 | CID000104802 | |
| Drug | Vitallium | 9.71e-05 | 244 | 23 | 4 | ctd:D014800 | |
| Drug | germanium monoxide | 1.07e-04 | 92 | 23 | 3 | CID006327639 | |
| Drug | ethylglutamate | 1.16e-04 | 16 | 23 | 2 | CID000014241 | |
| Drug | 2-PMPA | 1.16e-04 | 16 | 23 | 2 | CID010130754 | |
| Drug | pyrachlostrobin | 1.20e-04 | 811 | 23 | 6 | ctd:C513428 | |
| Drug | 3HPG | 1.32e-04 | 17 | 23 | 2 | CID000001217 | |
| Drug | acromelic acid A | 1.48e-04 | 18 | 23 | 2 | CID000108086 | |
| Drug | Chlorogenic Acid | 1.49e-04 | 103 | 23 | 3 | ctd:D002726 | |
| Drug | aminocyclopentane | 1.65e-04 | 19 | 23 | 2 | CID000002906 | |
| Drug | AC1L1C2F | 1.81e-04 | 110 | 23 | 3 | CID000001711 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 1.83e-04 | 20 | 23 | 2 | CID000001297 | |
| Drug | TAAD | 2.03e-04 | 21 | 23 | 2 | CID000133445 | |
| Drug | 3,4-dihydroxyphenylglycine | 2.03e-04 | 21 | 23 | 2 | CID000027915 | |
| Drug | MSOP | 2.44e-04 | 23 | 23 | 2 | CID003964633 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 2.66e-04 | 24 | 23 | 2 | CID003645780 | |
| Drug | 2,3-pentanedione | 2.90e-04 | 129 | 23 | 3 | ctd:C013186 | |
| Drug | AC1NQH9B | 3.13e-04 | 26 | 23 | 2 | CID005221504 | |
| Drug | BIBX1382BS | 3.13e-04 | 26 | 23 | 2 | CID006918508 | |
| Drug | benzylidenemalononitrile | 3.37e-04 | 27 | 23 | 2 | CID000017608 | |
| Drug | PBDA | 4.17e-04 | 30 | 23 | 2 | CID000004408 | |
| Drug | rosavin | 4.75e-04 | 32 | 23 | 2 | ctd:C529148 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 4.75e-04 | 32 | 23 | 2 | CID000001222 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 4.90e-04 | 373 | 23 | 4 | ctd:C540355 | |
| Drug | isodesmosine | 5.06e-04 | 33 | 23 | 2 | CID000013811 | |
| Drug | NSC49080 | 5.06e-04 | 33 | 23 | 2 | CID000002192 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 5.06e-04 | 33 | 23 | 2 | CID000002071 | |
| Drug | pomiferin | 5.06e-04 | 33 | 23 | 2 | ctd:C474837 | |
| Drug | losartan | 5.16e-04 | 378 | 23 | 4 | CID000003961 | |
| Drug | CPPG | 5.37e-04 | 34 | 23 | 2 | CID000002878 | |
| Drug | 1m5d | 5.69e-04 | 35 | 23 | 2 | CID000447082 | |
| Drug | Sistan | 6.02e-04 | 36 | 23 | 2 | CID003001858 | |
| Drug | benzyloxyaspartate | 6.36e-04 | 37 | 23 | 2 | CID004133412 | |
| Drug | L-BMAA | 6.71e-04 | 38 | 23 | 2 | CID000028558 | |
| Drug | 4CPG | 6.71e-04 | 38 | 23 | 2 | CID000005115 | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 7.07e-04 | 39 | 23 | 2 | CID003331970 | |
| Drug | DETC-MeSO | 7.07e-04 | 39 | 23 | 2 | CID003035711 | |
| Drug | Aspartylglutamate | 7.44e-04 | 40 | 23 | 2 | CID000151403 | |
| Drug | L000369 | 7.81e-04 | 41 | 23 | 2 | CID003931705 | |
| Drug | AC1NNRU4 | 7.81e-04 | 41 | 23 | 2 | CID005126051 | |
| Drug | butenafine | 8.20e-04 | 42 | 23 | 2 | CID000002484 | |
| Drug | LY341495 | 8.60e-04 | 43 | 23 | 2 | CID006324636 | |
| Drug | Joro spider toxin | 8.60e-04 | 43 | 23 | 2 | CID000119582 | |
| Drug | 17-isoprogesterone | 8.62e-04 | 1170 | 23 | 6 | CID000004920 | |
| Drug | nickel subsulfide | 8.69e-04 | 188 | 23 | 3 | ctd:C017557 | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.96e-04 | 190 | 23 | 3 | 5786_UP | |
| Drug | PbCl2 | 9.00e-04 | 44 | 23 | 2 | CID000024459 | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 9.09e-04 | 191 | 23 | 3 | 7417_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A | 9.23e-04 | 192 | 23 | 3 | 6875_UP | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 5824_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 6927_UP | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 3795_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; HL60; HG-U133A | 9.66e-04 | 195 | 23 | 3 | 1409_UP | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 7413_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 7435_UP | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 1293_DN | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 5089_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3742_DN | |
| Drug | Trapidil [15421-84-8]; Down 200; 19.4uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3136_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 7552_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 7495_DN | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3545_UP | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 5063_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 6027_UP | |
| Drug | cysteine sulfinic acid | 9.83e-04 | 46 | 23 | 2 | CID000000109 | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2141_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5238_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4160_UP | |
| Drug | Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2150_DN | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2716_DN | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5097_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 6310_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 6369_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2126_DN | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 2651_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 7363_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; HL60; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 2337_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 1298_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; HL60; HT_HG-U133A | 1.01e-03 | 198 | 23 | 3 | 2352_DN | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.59e-06 | 3 | 22 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 3.18e-06 | 4 | 22 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.23e-06 | 53 | 22 | 3 | C4707243 | |
| Disease | Dermatitis | 6.33e-05 | 16 | 22 | 2 | C0011603 | |
| Disease | breast carcinoma | 7.75e-05 | 1019 | 22 | 6 | EFO_0000305 | |
| Disease | Astigmatism | 1.18e-04 | 129 | 22 | 3 | HP_0000483 | |
| Disease | cortical thickness | 1.26e-04 | 1113 | 22 | 6 | EFO_0004840 | |
| Disease | Squamous cell carcinoma of lung | 2.60e-04 | 32 | 22 | 2 | C0149782 | |
| Disease | mortality | 2.81e-04 | 173 | 22 | 3 | EFO_0004352 | |
| Disease | Alzheimer disease | 4.17e-04 | 485 | 22 | 4 | MONDO_0004975 | |
| Disease | Congenital small ears | 4.28e-04 | 41 | 22 | 2 | C0152423 | |
| Disease | myopathy (implicated_via_orthology) | 5.86e-04 | 48 | 22 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 6.11e-04 | 49 | 22 | 2 | EFO_0006954, EFO_1001069 | |
| Disease | Alcoholic Intoxication, Chronic | 1.00e-03 | 268 | 22 | 3 | C0001973 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.01e-03 | 63 | 22 | 2 | DOID:0050866 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWDECCDCVGMCNPR | 66 | Q9GZX9 | |
| PMASSTCSCCWCCLG | 176 | Q5XKK7 | |
| MQPGDVCCWICIPCE | 521 | Q14832 | |
| SWGCCPMPQASCCED | 146 | P28799 | |
| PCTWVMACAYAPSGC | 146 | O14775 | |
| CSSECAPGMWGPQCD | 131 | Q5VY43 | |
| PPCCQFCEALQDACW | 406 | P39060 | |
| CNPWCPERCSGPMCT | 146 | Q9H0B8 | |
| QCVCEPGWTGPSCDC | 561 | P16144 | |
| PWFCDACKCGVSPSC | 371 | O94880 | |
| PPTNCCMSGCPNCVW | 86 | Q5BKU9 | |
| SCQKCDPSCPNGSCW | 186 | P00533 | |
| MQCCCDAGRCWSPGV | 356 | P35555 | |
| CEQCWPESGECGPCE | 366 | P29317 | |
| QKGTPCCWTCEPCDG | 536 | Q14831 | |
| CCCSKMPGEGWGDPC | 2126 | P35556 | |
| MPLSDWCCGICEEAP | 1 | Q1T7F1 | |
| WVCCCNSMVCNAGGP | 101 | Q99445 | |
| CCPEWECPCRCSMLS | 1526 | Q3ZCN5 | |
| SGQCCPTWHCECNCE | 2066 | Q3ZCN5 | |
| PGCEMCSTQRPCTWD | 366 | Q9H0F6 | |
| GLCSCDPNWMGPDCS | 721 | Q9NT68 | |
| CCCGPDFWDAHPDTC | 886 | Q0P6D6 | |
| YPGEECCSEWDCMCV | 61 | Q9Y5U5 | |
| CKWCVSCMQCGAASP | 1471 | O14686 |